Warren Olanow

6.2k total citations
16 papers, 1.5k citations indexed

About

Warren Olanow is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Warren Olanow has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Warren Olanow's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (6 papers) and Neurological and metabolic disorders (4 papers). Warren Olanow is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (6 papers) and Neurological and metabolic disorders (4 papers). Warren Olanow collaborates with scholars based in United States and United Kingdom. Warren Olanow's co-authors include N.-S. Chu, Chien‐Chung Huang, Chin‐Song Lu, Donald B. Calne, Burton P. Drayer, P. C. Burger, Stephen J. Riederer, R J Herfkens, G. Allan Johnson and D. B. Calne and has published in prestigious journals such as Neurology, Radiology and Neurosurgery.

In The Last Decade

Warren Olanow

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Warren Olanow United States	12	684	362	344	256	135	16	1.5k
N.-S. Chu Taiwan	17	475 0.7×	342 0.9×	555 1.6×	411 1.6×	107 0.8×	35	1.5k
Pramod Pal India	20	1.1k 1.6×	477 1.3×	204 0.6×	163 0.6×	94 0.7×	36	1.8k
Mohit Bhatt India	27	1.6k 2.3×	674 1.9×	239 0.7×	348 1.4×	234 1.7×	56	2.6k
Chin‐Song Lu Taiwan	16	479 0.7×	308 0.9×	206 0.6×	154 0.6×	205 1.5×	38	1.0k
Maria Morello Italy	22	222 0.3×	525 1.5×	144 0.4×	208 0.8×	405 3.0×	59	1.8k
Roger Pamphlett Australia	34	1.3k 1.9×	414 1.1×	635 1.8×	388 1.5×	832 6.2×	159	3.4k
Elise A. Malecki United States	13	374 0.5×	80 0.2×	264 0.8×	354 1.4×	130 1.0×	19	1.1k
Mario Zappia Italy	18	369 0.5×	228 0.6×	61 0.2×	69 0.3×	171 1.3×	39	991
Richard Imrich Slovakia	24	316 0.5×	124 0.3×	177 0.5×	106 0.4×	418 3.1×	112	2.1k
Stanley A. Benkovic United States	24	419 0.6×	575 1.6×	239 0.7×	254 1.0×	729 5.4×	34	2.8k

Countries citing papers authored by Warren Olanow

Since Specialization

Citations

This map shows the geographic impact of Warren Olanow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Olanow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Olanow more than expected).

Fields of papers citing papers by Warren Olanow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren Olanow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Olanow. The network helps show where Warren Olanow may publish in the future.

Co-authorship network of co-authors of Warren Olanow

This figure shows the co-authorship network connecting the top 25 collaborators of Warren Olanow. A scholar is included among the top collaborators of Warren Olanow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren Olanow. Warren Olanow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Moreadith, Randall W., Tacey X. Viegas, Michael D. Bentley, et al.. (2016). Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications. European Polymer Journal. 88. 524–552. 142 indexed citations

Watts, Ray L., Kelly E. Lyons, Rajesh Pahwa, et al.. (2010). Onset of dyskinesia with adjunct ropinirole prolonged‐release or additional levodopa in early Parkinson's disease. Movement Disorders. 25(7). 858–866. 75 indexed citations

Goetz, Christopher G., Joanne Wuu, Michael P. McDermott, et al.. (2008). Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Movement Disorders. 23(5). 690–699. 181 indexed citations

Zubair, Mohammed, Michael S. Jackson, Lance A. Smith, et al.. (2007). The administration of entacapone prevents l-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates. Experimental Neurology. 208(2). 177–184. 21 indexed citations

Bhattacharya, Kirsty, Daniela Saadia, Melvin D. Yahr, et al.. (2002). Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm.. PubMed. 59(5). 835–42. 117 indexed citations

Olanow, Warren. (2000). Cell death and neuroprotection in Parkinson's disease. Neurobiology of Aging. 21. 134–134. 5 indexed citations

Borlongan, Cesar V., Thomas B. Freeman, Kathleen A. Sherman, et al.. (1995). Cyclosporine-A Increases Spontaneous and Dopamine Agonist-Induced Locomotor Behavior in Normal Rats. Cell Transplantation. 4(1). 65–73. 8 indexed citations

Shinotoh, Hitoshi, B. J. Snow, Kellie A. Hewitt, et al.. (1995). MRI and PET studies of manganese‐intoxicated monkeys. Neurology. 45(6). 1199–1204. 97 indexed citations

Calne, Donald B., N.-S. Chu, Chien‐Chung Huang, Chin‐Song Lu, & Warren Olanow. (1994). Manganism and idiopathic parkinsonism. Neurology. 44(9). 1583–1583. 361 indexed citations

10.

Huang, Chin‐Chang, Chin-Song Lu, N.-S. Chu, et al.. (1993). Progression after chronic manganese exposure. Neurology. 43(8). 1479–1479. 151 indexed citations

11.

Drayer, Burton P., Warren Olanow, P. C. Burger, et al.. (1986). Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.. Radiology. 159(2). 493–498. 207 indexed citations

12.

Korobkin, Melvyn, et al.. (1983). Age-related changes in the thymus gland: CT-pathologic correlation. American Journal of Roentgenology. 141(2). 241–246. 49 indexed citations

13.

Friedman, Allan H., et al.. (1982). Pituitary Adenoma Presenting as Facial Pain. Neurosurgery. 10(6). 742–745. 7 indexed citations

14.

Korobkin, M, B. E. Powers, Warren Olanow, et al.. (1982). Thymoma detection by mediastinal CT: patient with myasthenia gravis. American Journal of Roentgenology. 138(2). 217–222. 18 indexed citations

15.

Olanow, Warren. (1981). Current Concepts in the Management of Movement Disorders. Neurosurgery. 28(Supplement 1). 137–170. 3 indexed citations

16.

Olanow, Warren & A. L. Finn. (1981). Phenytoin. Neurosurgery. 8(1). 112–117. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact